1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Anti-Infective Agents Market – By Type

1.3.2        North America Anti-Infective Agents Market – By Range

1.3.3        North America Anti-Infective Agents Market – By Route of Administration

1.3.4        North America Anti-Infective Agents Market – By Indication

1.3.5        North America Anti-Infective Agents Market – By Distribution Channel

1.3.6        North America Anti-Infective Agents Market – By Country

2.           North America Anti-Infective Agents Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Anti-infective Agents Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Anti-Infectives Agents Market – Key Market Dynamics

5.1         Key Drivers

5.1.1        Increasing Prevalence of Chronic Diseases

5.1.2        Surging Government Support for Research Activities and Clinical Trials

5.2         Market Restraints

5.2.1        Emergence of Anti-infective Drugs Resistance and Their Side Effects

5.3         Market Opportunities

5.3.1        Development of New Anti-infective Agents

5.4         Future Trends

5.4.1        Rising Investments in R&D Activities in Pharmaceutical Sector

5.5         Impact Analysis

6.           Anti-Infectives Agents Market – North America Analysis

6.1         North America Anti-Infectives Agents Market Revenue Forecast and Analysis

7.           North America Anti-Infectives Agents Market Analysis and Forecast to 2028 – Type

7.1         Overview

7.2         North America Anti-infectives Agents Market, by Type, 2022 & 2028 (%)

7.3         Anti-Viral

7.3.1        Overview

7.3.2        Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)

7.4         Anti-Bacterial

7.4.1        Overview

7.4.2        Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)

7.5         Anti-Fungal

7.5.1        Overview

7.5.2        Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others Market Revenue and Forecast to 2028 (US$ Million)

8.           North America Anti-Infectives Agents Market Analysis and Forecast to 2028 – Range

8.1         Overview

8.2         North America Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)

8.3         Narrow Spectrum

8.3.1        Overview

8.3.2        Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)

8.4         Broad Spectrum

8.4.1        Overview

8.4.2        Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Anti-Infectives Agents Market Analysis and Forecast to 2028 – Route of Administration

9.1         Overview

9.2         North America Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)

9.3         IV

9.3.1        Overview

9.3.2        IV Market Revenue and Forecast to 2028 (US$ Million)

9.4         Oral

9.4.1        Overview

9.4.2        Oral Market Revenue and Forecast to 2028 (US$ Million)

9.5         Topical

9.5.1        Overview

9.5.2        Topical Market Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Anti-Infectives Agents Market Analysis and Forecast to 2028 – Indication

10.1      Overview

10.2      North America Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)

10.3      HIV

10.3.1     Overview

10.3.2     HIV Market Revenue and Forecast to 2028 (US$ Million)

10.4      Tuberculosis

10.4.1     Overview

10.4.2     Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)

10.5      Respiratory Infection

10.5.1     Overview

10.5.2     Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)

10.6      Pneumonia

10.6.1     Overview

10.6.2     Pneumonia Market Revenue and Forecast to 2028 (US$ Million)

10.7      Others

10.7.1     Overview

10.7.2     Others Market Revenue and Forecast to 2028 (US$ Million)

11.        North America Anti-Infectives Agents Market Analysis and Forecast to 2028 – Distribution Channel

11.1      Overview

11.2      North America Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)

11.3      Hospital Pharmacies

11.3.1     Overview

11.3.2     Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.4      Retail Pharmacies

11.4.1     Overview

11.4.2     Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.5      Specialty Pharmacies

11.5.1     Overview

11.5.2     Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.6      E-Commerce

11.6.1     Overview

11.6.2     E-Commerce Market Revenue and Forecast to 2028 (US$ Million)

11.7      Others

11.7.1     Overview

11.7.2     Others Market Revenue and Forecast to 2028 (US$ Million)

12.        North America Anti-Infectives Agents Market Analysis and Forecasts To 2028 – Country Analysis

12.1      Overview

12.1.1     North America: Anti-Infective Agents Market, by Country, 2022 & 2028 (%)

12.1.1.1       US: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.1.1       Overview

12.1.1.1.2       US: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.1.3       US: Anti-Infective Agents Market, by Type, 2019–2028 (US$ Million)

12.1.1.1.4       US: Anti-Infective Agents Market, by Range, 2019–2028 (US$ Million)

12.1.1.1.5       US: Anti-Infective Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.1.1.6       US: Anti-Infective Agents Market, by Indications, 2019–2028 (US$ Million)

12.1.1.1.7       US: Anti-Infective Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.1.2       Canada: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.2.1       Overview

12.1.1.2.2       Canada: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.2.3       Canada: Anti-Infective Agents Market, by Type, 2019–2028 (US$ Million)

12.1.1.2.4       Canada: Anti-Infective Agents Market, by Range, 2019–2028 (US$ Million)

12.1.1.2.5       Canada: Anti-Infective Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.1.2.6       Canada: Anti-Infective Agents Market, by Indications, 2019–2028 (US$ Million)

12.1.1.2.7       Canada: Anti-Infective Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.1.3       Mexico: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.3.1       Overview

12.1.1.3.2       Mexico: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

12.1.1.3.3       Mexico: Anti-Infective Agents Market, by Type, 2019–2028 (US$ Million)

12.1.1.3.4       Mexico: Anti-Infective Agents Market, by Range, 2019–2028 (US$ Million)

12.1.1.3.5       Mexico: Anti-Infective Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.1.3.6       Mexico: Anti-Infective Agents Market, by Indications, 2019–2028 (US$ Million)

12.1.1.3.7       Mexico: Anti-Infective Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

13.        Anti-infectives Agents Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies In The Anti-infective agents Market, 2018-2022

13.3      Organic Developments

13.3.1     Overview

13.3.2     Organic Growth Strategies In The Anti-infective agents Market, 2018-2022

13.4      Inorganic Developments

13.4.1     Overview

13.4.2     Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022

14.        Anti-Infectives Agents Market- Company Profiles

14.1      Abbott

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Allergan Plc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Astellas Pharma Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Merck & Co., Inc.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Bayer AG

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Bristol-Myers Squibb Company

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Boehringer Ingelheim International GmbH

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      F. HOFFMANN-LA ROCHE LTD.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Gilead Sciences, Inc.

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   GlaxoSmithKline plc.

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

14.11   Novartis AG

14.11.1  Key Facts

14.11.2  Business Description

14.11.3  Products and Services

14.11.4  Financial Overview

14.11.5  SWOT Analysis

14.11.6  Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Anti-Infective Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Anti-Infective Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Anti-Infective Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Anti-Infective Agents Market, by Indications – Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Anti-Infective Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Anti-Infective Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Anti-Infective Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Anti-Infective Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada Anti-Infective Agents Market, by Indications – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Canada Anti-Infective Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Mexico Anti-Infective Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico Anti-Infective Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Mexico Anti-Infective Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Mexico Anti-Infective Agents Market, by Indications – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Mexico Anti-Infective Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Recent Inorganic Growth Strategies In The Anti-infective agents Market

Table 17.          Glossary of Terms, North America Anti-infectives Agents Market

LIST OF FIGURES

Figure 1.           North America Anti-Infective Agents Market Segmentation

Figure 2.           North America Anti-Infective Agents Market Segmentation, by Country

Figure 3.           North America Anti-infective agents Market Overview

Figure 4.           Anti-Viral Segment Held Largest Share of Product Segment in North America Anti-Infective Agents Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           North America Anti-Infectives Agents Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Anti-infectives agents Market– Revenue Forecast and Analysis – 2019 - 2028

Figure 10.        North America Anti-infectives Agents Market, by Type, 2022 & 2028 (%)

Figure 11.        North America Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        North America Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        North America Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)

Figure 16.        North America Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        North America Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        North America Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)

Figure 19.        North America IV Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        North America Oral Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Topical Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        North America Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        North America Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)

Figure 24.        North America HIV Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        North America Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        North America Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        North America Pneumonia Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        North America Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        North America Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)

Figure 30.        North America Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        North America Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

Figure 32.        North America Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

Figure 33.        North America E-Commerce Market Revenue and Forecast to 2028 (US$ Million)

Figure 34.        North America Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 35.        North America: Anti-Infective Agents Market, by Key Country – Revenue (2022) (US$ Million)

Figure 36.        North America: Anti-Infective Agents Market, by Country, 2022 & 2028 (%)

Figure 37.        US: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Canada: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Mexico: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Growth Strategies In The Anti-infective agents Market, 2018-2022

Figure 41.        Recent Organic Growth Strategies In The Anti-infective agents Market